Results 131 to 140 of about 198,913 (305)
International Journal of Cancer, EarlyView.ABSTRACT Many cervical screening programmes rely on cytology for triage of high‐risk human papillomavirus (hrHPV) positive women. However, cytological triage has variable and often limited sensitivity, and its availability can be restricted in resource‐poor settings.
Laura Burney Ellis +9 more
wiley +1 more source
International Journal of Infectious DiseasesIn the global effort to eliminate cervical cancer, high-quality Human Papillomavirus (HPV) testing is essential, especially in Peru where vaccination coverage remains incomplete. To ensure consistent nationwide test performance, the Peruvian HPV National
Pamela Rios-Monteza +8 more
doaj +1 more source
, 2014 BACKGROUND. Little is known about human papilloma virus (HPV) seroprevalence in the healthy Italian population. The aim of the study was to assess seroprevalence of antibodies against HPV 6, 11, 16 and 18 among girls and young women in Italy.
Silvia Lupi +8 more
core +1 more source
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 105-111, April 2025.Abstract Objective This study assessed the prevalence and factors associated with detecting cervical intraepithelial neoplasia grade 2 or higher (CIN2+) via endocervical curettage (ECC) during colposcopy. Methods Between December 2020 and September 2023, a prospective, cross‐sectional study involving women with abnormal cervical cancer screening ...
Nida Jareemit +8 more
wiley +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Background Lymphovascular space involvement (LVSI) is a significant prognostic factor of survival outcomes in gynecologic oncology. Synthetic studies on vulvar cancer are lacking as well as clear consensus about the importance of LSVI in vulvar cancer.
Vasilios Pergialiotis +6 more
wiley +1 more source
The effect of making a ‘third dose assumption’ on HPV coverage estimates
Australian and New Zealand Journal of Public Health, 2015 Julia M. Brotherton, Karen Winch
doaj +1 more source
Vaccinations in pregnancy: An update for a changing time
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Maternal immunization is one of the most effective public health interventions to reduce infectious morbidity and mortality in pregnant women, fetuses, and newborns. Despite robust evidence supporting vaccine safety and effectiveness in pregnancy, global uptake has declined following the COVID‐19 pandemic, contributing to resurgent outbreaks ...
Wendy Hodge +11 more
wiley +1 more source
Lactobacillus distribution in Lactobacillus-dominant HR-HPV-positive and HPV-negative samples (lactobacilli threshold >70%).
Jerzy Ostrowski (170111) +12 more
core +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Objective This study aims to evaluate the longitudinal clearance rates of high‐risk human papillomavirus (hr‐HPV) and the incidence of clinical recurrence (defined by abnormal cytology or histologically confirmed cervical intraepithelial neoplasia; CIN) at 6 and 18 months post‐loop electrosurgical excision procedure (LEEP), characterizing the ...
Praew Sittichivapak, Pattama Chaopotong
wiley +1 more source
International Journal of Gynecology &Obstetrics, EarlyView.Abstract Vaccination across the life course is a cornerstone of preventive health care for girls and women. Although WHO recommends completion of essential vaccines by adolescence, global coverage remains suboptimal. Vaccine‐preventable diseases—including HPV‐related cancers, vaginal, vulvar, anal, oropharyngeal, influenza, pertussis, hepatitis B ...
Hema Divakar +13 more
wiley +1 more source